Results 221 to 230 of about 2,058,358 (352)

Metabolomic Panel for the Diagnosis of Heart Failure with Preserved Ejection Fraction. [PDF]

Int J Mol Sci
Kozhevnikova MV, Kakotkina AV, Korobkova EO, Kuznetsov IV, Shestakova KM, Moskaleva NE, Appolonova SA, Belenkov YN.   +7 more
europepmc   +1 more source

Dilated cardiomyopathy evaluation with Imagenomics: combining multimodal cardiovascular imaging and genetics

ESC Heart Failure, EarlyView.
Systematic approach to dilated cardiomyopathy diagnosis. Dilated cardiomyopathy is a clinical diagnosis characterized by the presence of left ventricular dilatation and systolic disfunction unexplained by abnormal loading conditions or coronary artery disease.
Kristian Galanti, Ghaith Sharaf Dabbagh, Fabrizio Ricci, Sabina Gallina, Roberta Giansante, Ron Jacob, Edmond Obeng‐Gyimah, Leslie T. Cooper Jr, Sanjay K. Prasad, David H. Birnie, Andrew P. Landstrom, Selma F. Mohammed, Saidi Mohiddin, Mohammed Y. Khanji, Anwar A. Chahal   +14 more
wiley   +1 more source

Obesity-Related Phenotype of Heart Failure With Preserved Ejection Fraction: A Comprehensive Review. [PDF]

Cureus
El Hadj Othmane T, El Hadj Othmane O, Nizar H.   +2 more
europepmc   +1 more source

FACTORS THAT PRECIPITATE HOSPITALIZATIONS FOR HEART FAILURE WITH PRESERVED EJECTION FRACTION - CHARACTERISTICS AND IMPACT ON POST-DISCHARGE OUTCOME

, 2010
Dan Ruşinaru, Otilia Buiciuc, Franck Lévy, Marcel Peltier, Christophe Tribouilloy   +4 more
openalex   +1 more source

Pulmonary artery pressure trajectories in heart failure patients treated with GLP‐1 receptor agonists

ESC Heart Failure, EarlyView.
Abstract Aims Data support favourable haemodynamic benefits of glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) on improving cardiac structural abnormalities and function in patients with heart failure (HF). However, the direct haemodynamic effects of GLP‐1 RAs remain inadequately characterized.
Haoran Jiang, Phuuwadith Wattanachayakul, Veraprapas Kittipibul, Erika Nicolsen, Todd McVeigh, Oksana Kamneva, Marat Fudim   +6 more
wiley   +1 more source

Management of Patient With Tricuspid Regurgitation and Heart Failure With Preserved Ejection Fraction. [PDF]

JACC Case Rep
Bartkowiak J, Agarwal V, Otero D, Pinheiro Rezende C, Hahn RT.   +4 more
europepmc   +1 more source

HEART FAILURE WITH RECOVERED EJECTION FRACTION: A DISTINCT ENTITY WITHIN HEART FAILURE AND PRESERVED EJECTION FRACTION

, 2010
Lynn Punnoose, Parakash Pratibhu, Michael M. Givertz, Eldrin F. Lewis, Lynne W. Stevenson, Akshay S. Desai   +5 more
openalex   +1 more source

Acoustic features are independently associated with heart failure and pulmonary hypertension

ESC Heart Failure, EarlyView.
Abstract Introduction Acoustic analysis of speech has discriminated decompensated acute heart failure (HF). Speech rate (SR) and cepstral peak prominence (CPP) variation are among features previously evaluated. However, the association between SR and CPP and chronic stable HF with and without pulmonary hypertension (PH) as well as PH alone have not ...
Jaskanwal Deep S. Sara, Keiko Ishikawa, Yan Li, D.M. Anisuzzaman, Lilach O. Lerman, Amir Lerman, Diana Orbelo   +6 more
wiley   +1 more source

Non-Invasive Hemodynamic Assessment of Heart Failure With Preserved Ejection Fraction. [PDF]

Korean Circ J
Istratoaie S, Frost CL, Donal E.
europepmc   +1 more source

EVOLUTION‐HF DEallEF: A non‐interventional study of patients with heart failure initiated on dapagliflozin: study design

ESC Heart Failure, EarlyView.
Abstract Aims Heart failure (HF) is one of today's leading public health issues worldwide. The sodium‐glucose cotransporter 2 inhibitor (SGLT2i) dapagliflozin recently received a label expansion. It is now approved for treatment of HF across the entire spectrum of ejection fraction (EF) in Germany. However, real‐world data are limited.
Matthias Paul, Ralph Bosch, Behrus Subin, Angelika Guth, Marlena Mueller, Mareike Seelinger, Stephanie Riemann, Birgit Assmus   +7 more
wiley   +1 more source